STEPHEN J MCANDREW
CIK 1227041 · Chief Business Officer · last filed 2025-12-03
STEPHEN J MCANDREW is a Chief Business Officer who has filed 7 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for SONN, was dated Dec 3, 2025. Across all open-market trades the lifetime net is −$62.4K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
7
-$62.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Chief Business Officer | 0 | $1.26 | $0 | $0 | 2 | 2025-12-03 |
| Outlook Therapeutics, Inc. (ONSIW) Delisted | SVP Bus. Strat. & Dev. | — | — | — | $0 | 2 | 2018-10-24 |
| Outlook Therapeutics, Inc. (ONSIZ) Delisted | SVP Bus. Strat. & Dev. | 50,899 | — | — | -$62.4K | 3 | 2017-12-26 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-03 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Disp (D) | −6,446 | $0 | EDGAR |
| 2025-07-15 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2018-10-24 | Outlook Therapeutics, Inc. (ONSIW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-19 | Outlook Therapeutics, Inc. (ONSIW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-12-26 | Outlook Therapeutics, Inc. (ONSIZ) Delisted | Sell (S) | +15,705 | $17.7K | EDGAR |
| 2016-12-22 | Outlook Therapeutics, Inc. (ONSIZ) Delisted | Grant (A) | +30,000 | $0 | EDGAR |
| 2016-11-14 | Outlook Therapeutics, Inc. (ONSIZ) Delisted | Mixed | −21,367 | -$80.1K | EDGAR |